Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study).
Allavena C, Volteau C, André-Garnier E, Guimard T, Hall N, Khatchatourian L, Morrier M, Billaud E, Rodallec A, Reliquet V, Jovelin T, Le Guen L, Perré P, Grégoire M, Raffi F.
Allavena C, et al. Among authors: gregoire m.
Med Mal Infect. 2019 Oct;49(7):505-510. doi: 10.1016/j.medmal.2018.11.012. Epub 2018 Dec 21.
Med Mal Infect. 2019.
PMID: 30583867